AVALO THERAPEUTICS, INC. (AVTX) ROI
- 2019-09-30: ROI -69.36%.
- 2019-06-30: ROI -132.74%.
- 2019-03-31: ROI -113.39%.
- 2018-12-31: ROI -110.38%.
Complete source-backed roi history.
- Available history
- 2014-12-31 to 2019-09-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2019-09-30 | -69.36% |
| 2019-06-30 | -132.74% |
| 2019-03-31 | -113.39% |
| 2018-12-31 | -110.38% |
| 2018-09-30 | -107.66% |
| 2018-06-30 | 16.56% |
| 2018-03-31 | 24.89% |
| 2017-12-31 | 42.61% |
| 2017-09-30 | 60.23% |
| 2017-06-30 | -265.86% |
| 2017-03-31 | -519.44% |
| 2016-12-31 | -643.25% |
| 2016-06-30 | -135.84% |
| 2016-03-31 | -90.64% |
| 2015-12-31 | -56.26% |
| 2015-09-30 | 35.30% |
Annual ROI
| Date | ROI |
|---|---|
| 2018-12-31 | -110.38% |
| 2017-12-31 | 42.61% |
| 2016-12-31 | -643.25% |
| 2015-12-31 | -56.26% |
| 2014-12-31 | 83.99% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |